Clinical Trials Logo
  1. Home
  2. Hip Fractures
  3. NCT06180031
  4. Details
NCT06180031 Clinical Trial

Effect of Adding Magnesium Sulphate in Pericapsular Nerve Group Block

Hip Fractures Clinical Trial

— Peng Block  

Official title:
Effect of Adding Magnesium Sulphate to Bupivacaine in Ultrasound Guided Pericapsular Nerve Group Block for Post Operative Analgesia in Hip Joints Surgeries

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT06180031
Other study ID # 04-2023-200535
Secondary ID
Status Not yet recruiting
Phase Phase 2/Phase 3
First received
Last updated
Start date January 1, 2024
Est. completion date March 30, 2025

Study information
Verified date December 2023
Source Assiut University
Contact Mustafa M Bekhet, MBBCH
Phone +201060286688
Email mustafabekhet708@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Our aim will be to compare the analgesic efficacy and safety of magnesium sulphate as an adjuvant to bupivacaine in pericapsular nerve group block in Hip joint surgeries. - Our primary outcome of the study: total amount of postoperative morphine consumption in the first 24h postoperative. - Our secondary outcome of the study: mean arterial blood pressure, heart rate, respiratory rate, adverse effects, block related complication, sedation score (by Ramsay sedation scale) and pain score (by Visual Analog Scale)

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 62
Est. completion date March 30, 2025
Est. primary completion date January 1, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - • Patients aged 18 years or more. - Patients with American society of anesthesiologists (ASA) classification class I or II - Patients weight range from 50 to 90 Kgs Exclusion Criteria: - • Patient refusal of peripheral nerve block - Patient with infection at the site of injection - Patient with coagulopathy - Patients with known allergy to used medications.

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Pericapsular nerve group block using bupivicaine and magnesium sulphate
This technique involves the deposition of the local anesthetic in the fascial plane between the psoas muscle and the superior pubic ramus

Locations
Country Name City State
Egypt Assiut University Hospital Assiut

Sponsors (1)
Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome
Type Measure Description Time frame Safety issue
Primary Postoperative pain management total amount of postoperative morphine consumption in the first 24 hours postoperatively. 24 hours postoperatively
Secondary Visual analog scale It's a scale from 0 to 10 where 0 means no pain and 10 means worst pain imaginable 24 hours postoperatively
See also
  Status Clinical Trial Phase
Completed NCT02507609 - Deep Neuromuscular Block on Cytokines Release and Postoperative Delirium N/A
Completed NCT03906864 - Care Pathway for Sub-acute Hip Rehabilitation N/A
Recruiting NCT04063891 - Vibration Therapy as an Intervention for Enhancing Trochanteric Hip Fracture Healing in Elderly Patients N/A
Completed NCT05039879 - Life Improving Factors After a Hip Fracture
Not yet recruiting NCT03887494 - Study of the Impact of the Femoral Implant "Y-strut" on Lytic Bone Metastases of the Femoral Neck (WAZA-ARY) N/A
Terminated NCT03065101 - Trigen InterTAN vs Sliding Hip Screw RCT N/A
Completed NCT03545347 - Physiotherapy, Nutritional Supplement and Anabolic Steroids in Rehabilitation of Patients With Hip Fracture. Phase 2
Completed NCT03695081 - Patient Pathway Pharmacist - Optimal Drug-related Care N/A
Recruiting NCT05971173 - Nutritional Optimization and Bone Health Management for Older Adults Undergoing Hip Fracture Surgery Early Phase 1
Active, not recruiting NCT04957251 - Anterior vs Posterior Approach for Hip Hemiarthroplasty N/A
Terminated NCT04372966 - Uncemented Versus Cemented Total Hip Arthroplasty for Displaced Intracapsular Hip Fractures N/A
Withdrawn NCT05030688 - Fascia Iliaca Compartment Block and PENG Block for Hip Arthroplasty N/A
Completed NCT04424186 - 'Rehabilitation for Life' N/A
Not yet recruiting NCT04183075 - Impact of a Nutritional Supplement on the Recovery of the Nutritional Status of Patients With Spontaneous Hip Fracture N/A
Withdrawn NCT05518279 - Early Administration Of Tranexamic Acid And Acute Blood Loss In Patients With Hip Fractures Phase 3
Not yet recruiting NCT02892968 - ED Ultrasonographic Regional Anesthesia to Prevent Incident Delirium in Hip Fracture Patients N/A
Not yet recruiting NCT02223572 - Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture N/A
Active, not recruiting NCT02247791 - Uncemented Compared to Cemented Femoral Stems in Total Hip Arthroplasty N/A
Completed NCT00746876 - Unipolar or Bipolar Hemiarthroplasty in the Treatment of Displaced Femoral Neck Fractures. N/A
Completed NCT00058864 - The HIP Impact Protection Program (HIP PRO) N/A